NephroPlus secures Rs 850 crores investment by Quadria Capital to fuel its expansion plans

With this latest investment from Quadria Capital, NephroPlus is poised to expand high-quality dialysis services and address growing demand in India and across Asia

0
55
New Delhi: Asia’s largest dialysis network, NephroPlus, has secured an investment of Rs 850 Crore in Series F round from Quadria Capital, a leading healthcare-focused private equity firm in Asia. Through this deal, Quadria will obtain a substantial minority interest by combining a primary investment with the acquisition of shares from current stakeholders.
This investment, considered the largest ever in the Indian nephrology sector, marks a strategic partnership aimed at supporting NephroPlus in expanding its network across India and other Asian markets.
NephroPlus, founded in 2010, has emerged as a leading provider of dialysis services, serving patients across dialysis centers in major hospitals and standalone clinics. With a strong presence in India and a growing footprint in countries like the Philippines, NephroPlus is well-positioned to meet the increasing demand for high-quality and affordable dialysis services through public-private partnerships in both urban and rural areas.
With the demand for dialysis services projected to grow at a rate of over 11% annually in the coming years, specialized chains like NephroPlus are poised to gain market share. By outsourcing dialysis operations from hospitals and making high-quality services more accessible, NephroPlus aims to capitalize on this growth trajectory with Quadria’s support, leveraging its operational expertise and trusted relationships with nephrologists to further solidify its market leadership.
Vikram Vuppala, Founder and CEO of NephroPlus, expressed pride in the company’s growth, “Our business has evolved tremendously over the past few years and today we are proud to be one of the fastest growing and most trusted providers of high-quality dialysis to around 30,000 patients. We look forward to expanding in India, our core market, while exploring further opportunities to bring our expertise and clinical excellence to more patients in other global markets. Quadria’s healthcare expertise, capital and focus on operational value creation will put us in an even better position to keep scaling, innovating, and delivering affordable and high-quality care.”
Sunil Thakur, Partner and Head of South Asia at Quadria Capital, highlighted, “Quadria’s investment in NephroPlus underscores our ambition to invest in regional champions of Asian healthcare, who are providing high-quality, affordable healthcare to large, under-served populations. NephroPlus has demonstrated its ability to significantly improve health outcomes for its patients, whilst maintaining industry-leading growth and profitability. We look forward to working with their leadership team to continue to expand their footprint, increase access to dialysis services across Asia and accelerate the next phase of growth for NephroPlus.”